Delivery Order SPE2DB22D1002-SPE2DB24FLFR6
Award Date
7/30/24
Potential Completion Date
7/31/24
Potential Value
$9.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg autoinjectors, a medication used for the treatment of type 2 diabetes. The contract has a ceiling value of $4,157.22 and a period of performance through November 7, 2024. The contract is a firm fixed-price delivery order, and there is no set-aside designation...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the procurement of Bydureon BCise 2 mg autoinjectors. The contract has a ceiling value of $32,983.91 and a period of performance through November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg autoinjectors, a medication used to treat type 2 diabetes. The contract has a ceiling value of $3,240.42 and an ultimate completion date of March 31, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp holds a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon BCISE 2 mg autoinjector medication. The contract has a ceiling value of $5,436.04 and a period of performance through July 31, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, valued up to $999,999,999...
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product Bydureon BCISE 2 MG Autoject 0.85ML. The order has a ceiling value of $6,796.28 and an ultimate completion date of August 23, 2024. This contract is not set aside for any specific business type. AmerisourceBergen, a major pharmaceutical distributor, is delivering this product through an Indefinite Delivery Contract (IDC) valued up...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BYDUREON BCISE 2 MG AUTOINJECT 0.85ML medication. The contract has a ceiling value of $3,140.40 and a performance period ending on August 19, 2024. This award is not associated with a set-aside program. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon BCISE 2 mg autoinjector 0.85 ml. The contract has a ceiling value of $3,323.70 and a completion date of January 10, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, with a ceiling value of $47,211.38, is for the delivery of Bydureon BCISE 2 mg autoinjector 0.85 ml to support federal healthcare programs. The contract has an ultimate completion date of March 12, 2024 and is a firm fixed price delivery order. This award is associated with a larger Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Bydureon BCISE 2 mg auto-injector, a medication used in the treatment of type 2 diabetes. The contract has a ceiling value of $4,296.62 and an ultimate completion date of May 5, 2023. The contract is a firm fixed-price delivery order, without any set-aside designation,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Bydureon BCISE 2 mg autoinjector medical devices. The contract has a ceiling value of $3,487.79 and is a firm fixed-price delivery order. It is not designated as a set-aside contract. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...